Loading market data...
Latest Top News
AstraZeneca And Sun Pharma Join Forces To Expand Hyperkalaemia Treatment In India
AstraZeneca Pharma India Ltd will receive 260 million rupees from Sun Pharma as part of a strategic collaboration to market Sodium Zirconium Cyclosilicate (SZC) for hyperkalaemia treatment. AstraZeneca will sell the drug under the brand Lokelma, while Sun Pharma will market it as Gimliand, enhancing patient access nationwide.
Stay Ahead – Explore Now! Gujarat Inject Kerala Secures Large ₹144.9-Million Purchase Order






